Weight loss drug could be supplied to UK ‘in weeks’ after new format approval
by Ellie Ng
Jan 25, 2024
2 minutes
A weight loss drug newly approved in a four-dose injection pen format by the Medicines and Healthcare products Regulatory Agency (MHRA) could be supplied to the UK “within weeks”.
Mounjaro, also known as tirzepatide, is a diabetes drug that was authorised by the to help obese and overweight adults with weight management and loss in November last year.
You’re reading a preview, subscribe to read more.
Start your free 30 days